Safety and efficacy of favipiravir in COVID-19 patients with pneumonia. A randomized, double-blind, placebo-controlled study (FAVID)

被引：0

作者：

Juan P. Horcajada

Rebeca Aldonza

Mónica Real

Silvia Castañeda-Espinosa

Elena Sendra

Joan Gomez-Junyent

Inmaculada López-Montesinos

Silvia Gómez-Zorrilla

Silvia Briansó

Montserrat Duran-Taberna

Andrés Fernández

Cristina Tarragó

Teresa Auguet-Quintillá

机构：

[1] Universitat Pompeu Fabra (UPF),Department of Infectious Diseases, Hospital del Mar. IMIM, Passeig Marítim 25, 08003 Barcelona, Spain

[2] Instituto de Salud Carlos III,CIBERINFEC, CIBER of Infectious Diseases

[3] Clinical Development Lead,Service of the Internal Medicine

[4] Hospital Universitari de Tarragona Joan XXIII,Internal Medicine Service

[5] Universitat Rovira i Virgili,undefined

[6] IISPV,undefined

[7] Hospital Sant Pau i Santa Tecla,undefined

[8] Advanced Biotherapeutics Director,undefined

[9] R&D Project Lead,undefined

[10] GEMMAIR research group Institut d’Investigació Sanitària Pere Virgili (IISPV),undefined

来源：

Pneumonia | / 16卷

关键词：

Favipiravir; COVID-19; Pneumonia; Randomized clinical trial;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[41] Efficacy of oral amantadine among patients hospitalised with COVID-19: A randomised, double-blind, placebo-controlled, multicentre study
Barczyk, Adam
Czajkowska-Malinowska, Malgorzata
Farnik, Malgorzata
Barczyk, Marek
Boda, Lukasz
Cofta, Szczepan
Dulawa, Jan
Dyrbus, Maciej
Harat, Rafal
Huk, Maciej
Kotecka, Sylwia
Nahorecki, Artur
Nasilowski, Jacek
Naumnik, Wojciech
Przybylski, Grzegorz
Slabon-Willand, Monika
Skoczynski, Szymon
Wita, Krystian
Ziolo, Grzegorz
Kuna, Piotr
RESPIRATORY MEDICINE, 2023, 212
[42] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Julio Vallejos
Rodrigo Zoni
María Bangher
Silvina Villamandos
Angelina Bobadilla
Fabian Plano
Claudia Campias
Evangelina Chaparro Campias
Maria Fernanda Medina
Fernando Achinelli
Hector Andres Guglielmone
Jorge Ojeda
Diego Farizano Salazar
Gerardo Andino
Pablo Kawerin
Silvana Dellamea
Antonia Cristina Aquino
Victor Flores
Carolina N. Martemucci
Silvina Maria Martinez
Juan Emanuel Segovia
Paola Itati Reynoso
Noelia Carolina Sosa
Mariana Elizabeth Robledo
Joaquina Maria Guarrochena
Maria Mercedes Vernengo
Natalia Ruiz Diaz
Elba Meza
María Gabriela Aguirre
BMC Infectious Diseases, 21
[43] Randomized Double-Blind, Placebo-Controlled Feasibility Study, Evaluating the Efficacy of Homeopathic Medicines in the Prevention of COVID-19 in a Quarantined Population
Talele, Gitanjali
Vaidhya, Shashikant
Chowdhary, Abhay
Herscu, Paul
Shah, Rajesh
HOMEOPATHY, 2022, 111 (01) : 49 - 56
[44] Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19) a randomized, double-blind, placebo-controlled trial
Vallejos, Julio
Zoni, Rodrigo
Bangher, Maria
Villamandos, Silvina
Bobadilla, Angelina
Plano, Fabian
Campias, Claudia
Chaparro Campias, Evangelina
Fernanda Medina, Maria
Achinelli, Fernando
Andres Guglielmone, Hector
Ojeda, Jorge
Farizano Salazar, Diego
Andino, Gerardo
Kawerin, Pablo
Dellamea, Silvana
Cristina Aquino, Antonia
Flores, Victor
Martemucci, Carolina N.
Maria Martinez, Silvina
Emanuel Segovia, Juan
Itati Reynoso, Paola
Carolina Sosa, Noelia
Elizabeth Robledo, Mariana
Maria Guarrochena, Joaquina
Mercedes Vernengo, Maria
Ruiz Diaz, Natalia
Meza, Elba
Gabriela Aguirre, Maria
BMC INFECTIOUS DISEASES, 2021, 21 (01)
[45] Safety and efficacy of oral administrated cepharanthine in non-hospitalized, asymptomatic or mild COVID-19 patients: a Double-blind, randomized, placebo-controlled trial
Wei, Jianyi
Liu, Shupeng
Bian, Yuexiang
Li, Lei
Qian, Biyun
Shen, Zixuan
Zhang, Yan
Abuduaini, Adila
Dong, Fuchen
Zhang, Xin
Li, Jinhui
Yu, Yongpei
Zhang, Weituo
Wang, Jun
Zhai, Wei
Song, Qixiang
Zheng, Yu
Pan, Weihua
Yu, Lanlan
Zhan, Qimin
Zhang, Ning
Zheng, Junhua
Pan, Shuming
Yao, Chen
Li, Hai
SCIENTIFIC REPORTS, 2025, 15 (01):
[46] Efficacy and safety of vernakalant in patients with atrial flutter: a randomized, double-blind, placebo-controlled trial
Camm, A. John
Toft, Egon
Torp-Pedersen, Christian
Vijayaraman, Pugazhendhi
Juul-Moller, Steen
Ip, John
Beatch, Gregory N.
Dickinson, Garth
Wyse, D. George
EUROPACE, 2012, 14 (06): : 804 - 809
[47] SAFETY AND EFFICACY OF KARXT IN PATIENTS WITH SCHIZOPHRENIA IN THE RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED EMERGENT TRIALS
Kramer, Kenneth
Brannan, Stephen K.
Sauder, Colin
Kaul, Inder
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2025, 28 : i162 - i162
[48] Safety and efficacy of clonazepam in patients with hemifacial spasm: A double-blind, randomized, placebo-controlled trial
Seol-Hee, Baek
Je-Young, Shin
Sung-Yeon, Sohn
Kee, Hong Park
Jun-Soon, Kim
Bongjae, Kim
So, Hyun Ahn
Kyomin, Choi
Yoon-Ho, Hong
Sung, Jung-Joon
PARKINSONISM & RELATED DISORDERS, 2022, 103 : 1 - 6
[49] Efficacy and safety of CD24Fc in hospitalised patients with COVID-19: a randomised, double-blind, placebo-controlled, phase 3 study
Welker, James
Pulido, Juan D.
Tarizaro, Andrew T. Ca
Malvestutto, Carlos D.
Li, Zihai
Cohen, Jona Than B.
Whitman, Eric D.
Byrne, Dana
Giddings, Olivia K.
Lake, Jordan E.
Chua, Joel, V
Li, Ella
Chen, Flan
Zhou, Xiang
He, Kun
Gates, Davis
Kaur, Amarjot
Chen, Jamie
Chou, Hung-Yen
Devenport, Martin
Tommy, Raymond
Kottilil, Shyamasundaran
Liu, Yang
Zheng, Pan
LANCET INFECTIOUS DISEASES, 2022, 22 (05): : 611 - 621
[50] A Randomized, Double-Blind, Placebo-Controlled Study of Erenumab Safety in Patients with Stable Angina
Depre, C.
Antalik, L.
Starling, A. J.
Koren, M.
Eisele, O.
Mikol, D.
HEADACHE, 2018, 58 : 177 - 177

← 1 2 3 4 5 →